Biomedical nanotechnology represents a cutting-edge interdisciplinary field at the intersection of biology, medicine, and nanoscience. It involves the application of nanoscale materials, devices, and techniques to address challenges in healthcare and enhance medical processes. The use of nanotechnology in the biomedical field offers unique opportunities for diagnostics, treatment, and monitoring of various diseases at the molecular and cellular levels. Nanoscale materials, often ranging from 1 to 100, exhibit distinct properties that can be tailored for specific biomedical applications. These applications include targeted drug delivery systems, advanced imaging modalities, biosensors for early disease detection, and nanoscale devices designed to interact with biological systems. The precision and versatility offered by biomedical nanotechnology hold tremendous promise for revolutionizing medical practices, improving patient outcomes, and advancing our understanding of complex biological processes. As researchers continue to explore and refine nanotechnological approaches, the potential for groundbreaking developments in personalized medicine, regenerative therapies, and disease prevention becomes increasingly tangible.
Title : Renewed novel biotech ideas, with bioreactor bioengineering economic impact
Murray Moo Young, University of Waterloo, Canada
Title : Osmotic lysis–driven Extracellular Vesicle (EV) engineering
Limongi Tania, University of Turin, Italy
Title : Bioherbicides for eco-friendly weed management: From fields to commercialization, constraints and solutions for sustainable agriculture
K R Aneja, Kurukshetra University, India
Title : Predicting wound closure and future segmentation masks in wound healing assays
Alfredo De Cillis, Univeristy of Salento, CNR Nanotec, Italy
Title : Utilizing complex coacervation to promote the controlled crystallization of hydrophobic drugs
Anvesha Subramanian, University of Houston, United States
Title : Improving health in over 40,000 patients: The impact of nanomedicine fighting antibiotic resistant infections
Thomas J Webster, Brown University, United States